Home > Publications database > Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. > print

001     134812
005     20240229105042.0
024 7 _ |a 10.1002/cam4.1445
|2 doi
024 7 _ |a pmid:29608257
|2 pmid
024 7 _ |a pmc:PMC5943470
|2 pmc
024 7 _ |a altmetric:35164332
|2 altmetric
037 _ _ |a DKFZ-2018-00603
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Painter, Jodie N
|0 0000-0002-4992-2458
|b 0
245 _ _ |a Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses.
260 _ _ |a Hoboken, NJ
|c 2018
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1660114193_23718
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Epidemiological, biological, and molecular data suggest links between endometriosis and endometrial cancer, with recent epidemiological studies providing evidence for an association between a previous diagnosis of endometriosis and risk of endometrial cancer. We used genetic data as an alternative approach to investigate shared biological etiology of these two diseases. Genetic correlation analysis of summary level statistics from genomewide association studies (GWAS) using LD Score regression revealed moderate but significant genetic correlation (rg  = 0.23, P = 9.3 × 10-3 ), and SNP effect concordance analysis provided evidence for significant SNP pleiotropy (P = 6.0 × 10-3 ) and concordance in effect direction (P = 2.0 × 10-3 ) between the two diseases. Cross-disease GWAS meta-analysis highlighted 13 distinct loci associated at P ≤ 10-5 with both endometriosis and endometrial cancer, with one locus (SNP rs2475335) located within PTPRD associated at a genomewide significant level (P = 4.9 × 10-8 , OR = 1.11, 95% CI = 1.07-1.15). PTPRD acts in the STAT3 pathway, which has been implicated in both endometriosis and endometrial cancer. This study demonstrates the value of cross-disease genetic analysis to support epidemiological observations and to identify biological pathways of relevance to multiple diseases.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a O'Mara, Tracy A
|b 1
700 1 _ |a Morris, Andrew P
|b 2
700 1 _ |a Cheng, Timothy H T
|b 3
700 1 _ |a Gorman, Maggie
|b 4
700 1 _ |a Martin, Lynn
|b 5
700 1 _ |a Hodson, Shirley
|b 6
700 1 _ |a Jones, Angela
|b 7
700 1 _ |a Martin, Nicholas G
|b 8
700 1 _ |a Gordon, Scott
|b 9
700 1 _ |a Henders, Anjali K
|b 10
700 1 _ |a Attia, John
|b 11
700 1 _ |a McEvoy, Mark
|b 12
700 1 _ |a Holliday, Elizabeth G
|b 13
700 1 _ |a Scott, Rodney J
|b 14
700 1 _ |a Webb, Penelope M
|b 15
700 1 _ |a Fasching, Peter A
|0 0000-0003-4885-8471
|b 16
700 1 _ |a Beckmann, Matthias W
|b 17
700 1 _ |a Ekici, Arif B
|b 18
700 1 _ |a Hein, Alexander
|b 19
700 1 _ |a Rübner, Matthias
|b 20
700 1 _ |a Hall, Per
|b 21
700 1 _ |a Czene, Kamila
|b 22
700 1 _ |a Dörk, Thilo
|0 0000-0002-9458-0282
|b 23
700 1 _ |a Dürst, Matthias
|b 24
700 1 _ |a Hillemanns, Peter
|b 25
700 1 _ |a Runnebaum, Ingo
|b 26
700 1 _ |a Lambrechts, Diether
|0 0000-0002-2402-4029
|b 27
700 1 _ |a Amant, Frederic
|b 28
700 1 _ |a Annibali, Daniela
|b 29
700 1 _ |a Depreeuw, Jeroen
|b 30
700 1 _ |a Vanderstichele, Adriaan
|b 31
700 1 _ |a Goode, Ellen L
|0 0000-0002-9094-8326
|b 32
700 1 _ |a Cunningham, Julie M
|b 33
700 1 _ |a Dowdy, Sean C
|b 34
700 1 _ |a Winham, Stacey J
|b 35
700 1 _ |a Trovik, Jone
|b 36
700 1 _ |a Hoivik, Erling
|b 37
700 1 _ |a Werner, Henrica M J
|b 38
700 1 _ |a Krakstad, Camilla
|b 39
700 1 _ |a Ashton, Katie
|b 40
700 1 _ |a Otton, Geoffrey
|b 41
700 1 _ |a Proietto, Tony
|b 42
700 1 _ |a Tham, Emma
|b 43
700 1 _ |a Mints, Miriam
|b 44
700 1 _ |a Ahmed, Shahana
|b 45
700 1 _ |a Healey, Catherine S
|b 46
700 1 _ |a Shah, Mitul
|b 47
700 1 _ |a Pharoah, Paul D P
|b 48
700 1 _ |a Dunning, Alison M
|b 49
700 1 _ |a Dennis, Joe
|b 50
700 1 _ |a Bolla, Manjeet K
|b 51
700 1 _ |a Michailidou, Kyriaki
|b 52
700 1 _ |a Wang, Qin
|b 53
700 1 _ |a Tyrer, Jonathan P
|b 54
700 1 _ |a Hopper, John L
|b 55
700 1 _ |a Peto, Julian
|b 56
700 1 _ |a Swerdlow, Anthony J
|b 57
700 1 _ |a Burwinkel, Barbara
|0 P:(DE-He78)15b7fd2bc02d5ef47a2fe2dd0140d2bf
|b 58
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 59
700 1 _ |a Meindl, Alfons
|b 60
700 1 _ |a Brauch, Hiltrud
|0 P:(DE-HGF)0
|b 61
700 1 _ |a Lindblom, Annika
|b 62
700 1 _ |a Chang-Claude, Jenny
|0 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
|b 63
700 1 _ |a Couch, Fergus J
|b 64
700 1 _ |a Giles, Graham G
|b 65
700 1 _ |a Kristensen, Vessela N
|b 66
700 1 _ |a Cox, Angela
|b 67
700 1 _ |a Zondervan, Krina T
|b 68
700 1 _ |a Nyholt, Dale R
|b 69
700 1 _ |a MacGregor, Stuart
|b 70
700 1 _ |a Montgomery, Grant W
|b 71
700 1 _ |a Tomlinson, Ian
|b 72
700 1 _ |a Easton, Douglas F
|b 73
700 1 _ |a Thompson, Deborah J
|b 74
700 1 _ |a Spurdle, Amanda B
|b 75
773 _ _ |a 10.1002/cam4.1445
|g Vol. 7, no. 5, p. 1978 - 1987
|0 PERI:(DE-600)2659751-2
|n 5
|p 1978 - 1987
|t Cancer medicine
|v 7
|y 2018
|x 2045-7634
909 C O |p VDB
|o oai:inrepo02.dkfz.de:134812
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 58
|6 P:(DE-He78)15b7fd2bc02d5ef47a2fe2dd0140d2bf
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 59
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 61
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 63
|6 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Cancer risk factors and prevention
|x 0
914 1 _ |y 2018
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER MED-US : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 0
920 1 _ |0 I:(DE-He78)G110-20160331
|k G110
|l Präventive Onkologie
|x 1
920 1 _ |0 I:(DE-He78)L101-20160331
|k L101
|l DKTK Heidelberg
|x 2
920 1 _ |0 I:(DE-He78)C080-20160331
|k C080
|l Molekulare Epidemiologie
|x 3
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 4
920 1 _ |0 I:(DE-He78)L801-20160331
|k L801
|l DKTK Tübingen
|x 5
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)G110-20160331
980 _ _ |a I:(DE-He78)L101-20160331
980 _ _ |a I:(DE-He78)C080-20160331
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a I:(DE-He78)L801-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21